Gene and Cell Therapy – News and Features
News
Cognate Therapeutics Changes Name to Cognate BioServices
As a provider of services in the biotechnology field, Cognate changed its name to better reflect its focus.
News
National Children's Leukemia Foundation Endorses Missouri Stem Cell Research and Cures Initiative
The Initiative ensures that Missouri patients will have access to any federally approved stem cell cures that are available to other Americans.
News
Developments Improve Safety of Stem Cell Transplantation in the Treatment of Leukaemia
Study shows that a 'suicide' gene can be used to cut short rejection reactions following stem cell transplants.
News
Children's Hospital Boston Researchers to Create Embryonic Stem Cells
Researchers are creating human embryonic stem cells using nuclear transfer with human eggs and embryos.
News
Inovio at ASGT 9th Annual Meeting
Inovio’s presentation showcase potential for electroporation in delivering DNA vaccines.
News
PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"
The presentation will be given on June 9, 2006 at the Hyatt Regency Hotel in San Francisco at 3:30 pm pacific time.
News
Moffitt and Inovio Announce Positive Results from Human Study of Plasmid DNA Delivery Using Electroporation
Collaborators encouraged by interim data from phase I clinical study of patients with malignant melanoma.
News
Bioheart and PharmaCell Open GMP Lab Facility in Europe
This lab is an advanced research facility that also has GMP cell production capabilities to support research related to Bioheart's adult muscle stem cell technology.
News
Inovio Highlights Clinical and Technology Platforms for DNA Vaccines
The technology, based on the process of electroporation, uses extremely short electrical field pulses to temporarily open cell.
News
Culture of Human Embryonic Stem Cells for Therapeutic Use
Research shows that human embryonic stem cells can be grown using Tissue Therapies' VitroGro®.
Advertisement
